Table 2. Summary of the pre-S genotyping results by IHC-based analysis in 30 HBV-related HCC patients.

Summary of The Pre-S Genotyping Resultsa	IHC-Based Analysis
Total patients (n) (%)	30 (100)
Patients without type I and type II GGH (n) (%)	11 (37)
Patients with type I and/or type II GGH (n) (%)	19 (63)
Patients with type I GGH (score 1–4) and type II GGH (score 0) (n) (%)	4 (13)
Patients with type I GGH (score 0) and type II GGH (score 1–4) (n) (%)	6 (20)
Patients with type I GGH (score 1–4) and type II GGH (score 1–4) (n) (%)	9 (30)
Patients with type I GGH (score 1–4) and type II GGH (score 0–4) (n) (%)	13 (43)
Patients with type II GGH (score 1–4) and type I GGH (score 0–4) (n) (%)	15 (50)

^aThe percentage of each type of GGH was scored from 0 to 4 corresponding to 0%, <5%, 5% to 9%, 10% to 29%, and ≥30% of hepatocytes in liver tissues, respectively.

Abbreviations: IHC, immunohistochemistry; GGH, ground glass hepatocytes; n, number; del, deletion.